Susquehanna International Group
HTGM

Susquehanna International Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Susquehanna International Group’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,288
Closed -$17K – 14383
2022
Q3 		$17K Sell
2,288
-5,967
-72% -$72.6K ﹤0.01% 12662
2022
Q2 		$102K Buy
+8,255
New +$77.4K ﹤0.01% 11462
2020
Q2 		– Sell
-196
Closed -$11K – 11225
2020
Q1 		$11K Buy
196
+79
+68% +$7.73K ﹤0.01% 10041
2019
Q4 		$15K Buy
+117
New +$15.8K ﹤0.01% 9521
2018
Q4 		– Sell
-128
Closed -$116K – 10286
2018
Q3 		$116K Buy
+128
New +$84.5K ﹤0.01% 8546

Other funds holding HTGM

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Susquehanna International Group's HTGM Position: Q4 2022 in Review

Susquehanna International Group sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2022, closing a stake of 2,288 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in HTGM in Q3 2018 and held it in 5 quarters. The position peaked at $116K in Q3 2018. 10 funds tracked by Wall St. Rank hold HTGM as of Q4 2022.

  • Susquehanna International Group reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 2,288 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2022, an estimated $17K.
  • Susquehanna International Group first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Susquehanna International Group's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $116K in Q3 2018.
  • 10 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.